Table 3.
Efficacy of combination regimens using fludarabine plus concurrent monoclonal antibodies in chronic lymphocytic leukemia (CLL) in Phase II trials.
Abbreviations: CR, complete response; CYC, cyclophosphamide; FLU, fludarabine; PR, partial response.* Rituximab 375 mg/m2 course 1500 mg/m2 all subsequent courses.
